The cleaning guru is back with a new eco-range, The Fill
Non-binding vote on psychedelic drug will carry weight with FDA in blow to pharmaceutical developers
Chronic NHS backlogs led to a 7% rise in private admissions between 2022-23
Ruling means plaintiffs can present evidence alleging link between heartburn drug and cancer
Radical advances in neurotechnology are helping disabled people walk and could provide the link between human and artificial intelligence
Analysts warn a key driver of US employment growth could be under threat
Experts warn that epidemics of the mosquito-born virus will become more common as a result of climate change
World’s largest food group wants to focus on products that boost health of elderly
Judge rules experts’ evidence admissible, leaving route open for 72,000 cancer sufferers to bring cases
US decision hands biotech group its first regulatory blessing since its blockbuster Covid-19 jab
The writer and campaigner on love, last wishes and the divisive debate over assisted dying
Funding would help to bolster stockpile as CDC reports third dairy worker infected
People with cystic fibrosis, epilepsy and diabetes among those struggling with medicine shortages
US group hopes EyeBio will refill its pipeline with treatments targeting causes of blindness
Paying for overnight childcare for employees could increase pressure on new parents to return to their job
Solving the issue needs to be a bipartisan effort
Most companies have succession plans for senior staff but few prepare for the emotional fallout of losing a colleague
Stockpiling is no longer the preserve of the conspiracy-minded
Fatalities increasing in many parts of world less successful in reducing dangerous pollutants, says research
US drugmaker races to scale up ingredient production to meet demand for Mounjaro and Zepbound jabs
Despite a growing body of evidence, Big Food is trying to dampen fears about the health effects of industrially formulated substances
As Covid revenues slump, technology developed to fight the pandemic is having some success combating this disease
Anopheles stephensi modified so that the biting females would die
Fears of growing outbreak drive revival in vaccine group stocks which have been out of favour since pandemic ended
An FT special report looking at changes in healthcare, treatments and illness itself
UK Edition
